Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (431-440 of 545) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatinM Markman, R Rothman, T Hakes, et al.
Pediatric Blood & Cancer|April 29, 2017
Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancyTimothy M Markman, Kathryn Ruble, David Loeb, et al.
Gynecologic Oncology|November 11, 1991
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapyB Reichman, M Markman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant diseaseM Markman, T Hakes, B Reichman, et al.
American Journal of Obstetrics and Gynecology|March 1, 1989
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancerS C Rubin, W J Hoskins, T B Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancerM Markman, M George, T Hakes, et al.
Gynecologic Oncology|March 30, 1999
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancerA Husain, P Sabbatini, D Spriggs, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfateM Markman, R D'Acquisto, N Iannotti, et al.
Journal of Neurodevelopmental Disorders|November 22, 2011
Language development after cochlear implantation: an epigenetic modelTimothy M Markman, Alexandra L Quittner, Laurie S Eisenberg, et al.
Applied Clinical Informatics|October 25, 2013
Medical student appraisal: electronic resources for inpatient pre-roundingP J Sampognaro, S L Mitchell, S R Weeks, et al.
Pageof 55

Showing results (431-440 of 545) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatinM Markman, R Rothman, T Hakes, et al.
Pediatric Blood & Cancer|April 29, 2017
Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancyTimothy M Markman, Kathryn Ruble, David Loeb, et al.
Gynecologic Oncology|November 11, 1991
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapyB Reichman, M Markman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant diseaseM Markman, T Hakes, B Reichman, et al.
American Journal of Obstetrics and Gynecology|March 1, 1989
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancerS C Rubin, W J Hoskins, T B Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancerM Markman, M George, T Hakes, et al.
Gynecologic Oncology|March 30, 1999
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancerA Husain, P Sabbatini, D Spriggs, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfateM Markman, R D'Acquisto, N Iannotti, et al.
Journal of Neurodevelopmental Disorders|November 22, 2011
Language development after cochlear implantation: an epigenetic modelTimothy M Markman, Alexandra L Quittner, Laurie S Eisenberg, et al.
Applied Clinical Informatics|October 25, 2013
Medical student appraisal: electronic resources for inpatient pre-roundingP J Sampognaro, S L Mitchell, S R Weeks, et al.
Pageof 55